<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03554876</url>
  </required_header>
  <id_info>
    <org_study_id>FIBEA-06-EC/17/Multi-Im</org_study_id>
    <nct_id>NCT03554876</nct_id>
  </id_info>
  <brief_title>Randomized and Controlled Clinical Trial to Evaluate Bacterial Adhesion on Multi-Im® Transepithelial Components</brief_title>
  <official_title>Randomized and Controlled Clinical Trial to Evaluate Bacterial Adhesion on Multi-Im® Transepithelial Components Placed on Implants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Eduardo Anitua</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación Eduardo Anitua</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the efficacy of Mutli-Im® transepithelial components in the inhibition
      of bacterial adhesion.

      The control group will be the Multi-Im® transepithelial component with the conventional
      surface (Multi-IM® Machined) and the experimental group will be the Multi-Im transepithelial
      components with the Ti-Golden® surface (Multi-Im Golden) or with the nanogolden surface
      (Multi-Im® nanogolden). Periodontal indices and biofilformation will be assessed during 2
      months after implant loading. Metagenomic analysis and PCR technique will be implemented to
      assess the biofilm formation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 16, 2018</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total amount of the 25 most relevant bacterial species in peri-implantitis processes measured in the retired Multi-Im implants</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Total amount of the 25 most relevant bacterial species in peri-implantitis processes</measure>
    <time_frame>2 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total number of bacterial species.</measure>
    <time_frame>24 hours, 2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total amount of the 6 most abundant bacterial species.</measure>
    <time_frame>24 hours, 2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dental plaque index</measure>
    <time_frame>Baseline, 24 hours, 2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gingival index of the natural teeth</measure>
    <time_frame>Baseline, 24 hours, 2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Probing depth of natural teeth</measure>
    <time_frame>Baseline, 24 hours, 2 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Biofilm Formation</condition>
  <arm_group>
    <arm_group_label>Multi-Im Machined</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Multi-Im Machined</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multi-Im® nanogolden</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Multi-Im® nanogolden</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multi-Im T-Golden</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Multi-Im T-Golden</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Multi-Im Machined transepithelial component.</intervention_name>
    <description>Once the implant is placed, the implant loading protocol will be decided following the clinical criteria. When implant loading is to be done, then the Multi-IM machined transepithelial component is connected to the implant.</description>
    <arm_group_label>Multi-Im Machined</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Multi-Im Nanogolden transepithelial component</intervention_name>
    <description>Once the implant is placed, the implant loading protocol will be decided following the clinical criteria. When implant loading is to be done, then the Multi-IM Nanogolden transepithelial component is connected to the implant.</description>
    <arm_group_label>Multi-Im® nanogolden</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Multi-Im Ti-Golden transepithelial component</intervention_name>
    <description>Once the implant is placed, the implant loading protocol will be decided following the clinical criteria. When implant loading is to be done, then the Multi-IM Ti-Golden transepithelial component is connected to the implant.</description>
    <arm_group_label>Multi-Im T-Golden</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Indication of having to place at least three dental implants.

          -  Plate index ≤ 20% and absence of evidence of active periodontal disease.

          -  Bleeding index of adjacent teeth ≤ 30%.

          -  Probing depth in adjacent teeth &lt;4 mm.

          -  Not having used systemic antibiotics during the last 6 months.

          -  Non smoker.

          -  Possibility for observation during the treatment period.

          -  Having signed the informed consent.

        Exclusion Criteria:

          -  Suffering any alteration or serious hematologic disease.

          -  Being undergoing or having received in the 30 days prior to inclusion:

        radiotherapy, chemotherapy or immunosuppressive treatments, systemic corticosteroids and/or
        anticoagulants.

          -  Presence of malignant tumors, hemangiomas or angiomas in the area of implant
             placement.

          -  Patients undergoing treatment with bisphosphonate drugs, both orally and
             intravenously.

          -  Metabolic bone disease.

          -  Diseases that affect the oral mucosa.

          -  Diabetic patients.

          -  Severe parafunctional habits and/or temporomandibular joint disorders.

          -  Pregnant or lactating women.

          -  Physical or mental inability to maintain a good oral hygiene.

          -  Being participating in another study.

          -  In general, any inability to participate in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mohammad Hamdan, PhD</last_name>
    <phone>0034945160653</phone>
    <email>mohammad.hamdan@bti-implant.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clínica Eduardo Anitua</name>
      <address>
        <city>Vitoria</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduardo Anitua</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 30, 2018</study_first_submitted>
  <study_first_submitted_qc>June 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 13, 2018</study_first_posted>
  <last_update_submitted>August 2, 2019</last_update_submitted>
  <last_update_submitted_qc>August 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Biofilm</keyword>
  <keyword>peri-implantitis</keyword>
  <keyword>metagenomic analysis</keyword>
  <keyword>abutment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tissue Adhesions</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

